Corporate Support
Sitemap

Features

Customer Services

Events

Terms of Use

Singapore
Malaysia

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,116.2
-8.3 (-0.27%)

 

  • STI Straits Times Index
    3,116.2
    -8.3 (-0.27%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,566.2
    -1.4 (-0.09%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,503.9
    -17.9 (-0.07%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,991.0
    -16.8 (-0.56%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,207.2
    408.3 (1.87%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,158.2
    31.3 (0.51%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,068.2
    0.8 (0.04%)
    Index delayed 20 minutes
  • XAO XAO
    6,763.3
    5.4 (0.08%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 611.1M
  • Value: 698.1M
  • Rise: 139
  • Fall: 151
  • Unch: 542

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol

  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Golden Agri-Res0.215+0.005
Y Ventures0.117+0.005
Spackman0.014+0.001
Rex Intl0.079-
G Invacom^0.156+0.006
YZJ Shipbldg SGD0.970-0.005
Singapore-eDev0.050+0.003
Genting Sing0.920+0.005
AEM1.230+0.040
Ley Choon0.017+0.002

World Indices

World Indices
Name Last Change
Nasdaq 8,048.6 -8.4
HSI 26,503.9 -17.9
HSCEI 10,500.2 -7.7
Jakarta 6,158.2 +31.3
Nikkei 225 22,207.2 +408.3
SSE Comp 2,991.0 -16.8
Shanghai A 3,133.5 -17.6
Shanghai B 269.9 -1.2
PSE Comp 0.0
KOSPI 2,068.2 +0.8

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help

  • Factsheet

  • Print

10X GENOMICS INC 10X GENOMICS INC CLASS A
Updated on 14 Oct 2019 (End of trading day)
Last (USD): 50.260 Change: +0.960 High: 51.220 Remarks: -
Change (%): +1.95 Low: 49.000
Open 49.310 Yesterday's Close 49.3
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 83,555 Cumulative Value
 
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -2.87022 Trailing EPS (USD) e -2.68900 NAV (USD) b -5.8164
PE a - Trailing PE f - Price / NAV b -8.6411
Dividend (USD) d - Cash In Hand (USD) g 1.4298 Issued & Paid-up Shares c 19,595,000
Dividend Yield (%) d - Price / Cash In Hand g 35.152 Treasury Shares h -
Beta - 75 Daysi -0.791 R-Squared - 75 Days(%)i 2.91 Market Cap (M) 1,969.710
Beta - 500 Daysi -0.785 R-Squared - 500 Days (%)i 2.94 Enterprise Value (M) 2,186.584
Piotroski F Score 4 Exchange Code TXG Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 31.5
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 17 Sep 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 09 Sep 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference 10X GENOMICS INC NASDAQ 1,969.710 - - -8.6411 -
Industry Biotechnology NASDAQ 2,149.296 127.491 97.699 5.0069 0.822
Local Peer AMGEN INC NASDAQ 121,673.336 14.495 15.289 11.2723 2.732
Local Peer GILEAD SCIENCES INC NASDAQ 81,698.689 14.977 13.719 3.6124 3.578
Local Peer CELGENE CORP NASDAQ 71,150.509 17.585 13.498 7.0789 -
Local Peer ILLUMINA INC NASDAQ 45,615.570 55.225 48.631 10.5299 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 44,618.706 21.284 20.144 8.8006 -
Local Peer BIOGEN INC NASDAQ 41,640.755 9.398 7.866 3.2148 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 33,566.130 13.732 16.221 3.4406 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 22,723.164 292.822 17.039 2.2358 -
Local Peer INCYTE CORPORATION NASDAQ 16,659.090 152.148 54.465 7.4133 -
Local Peer SEATTLE GENETICS INC NASDAQ 13,917.688 - - 10.9431 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 12,067.092 - - 4.0754 -
Local Peer EXACT SCIENCES CORP NASDAQ 12,281.652 - - 16.0434 -
Other Local Peers GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), EXELIXIS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), MODERNA INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), REPLIGEN CORP (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), FIBROGEN INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALKERMES PLC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), NATERA INC (NASDAQ), GENOMIC HEALTH INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ACCELERON PHARMA (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), ALDER BIOPHARMACEUTICALS INC (NASDAQ), INSMED INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), OPKO HEALTH INC (NASDAQ), VERACYTE INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), EDITAS MEDICINE INC (NASDAQ), VIELA BIO INC (NASDAQ), INTREXON CORP (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), EPIZYME INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), OMEROS CORP (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), CYTOKINETICS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), NEXTCURE INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), ARVINAS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), MACROGENICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), TRANSLATE BIO INC (NASDAQ), RETROPHIN INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), UROGEN PHARMA LTD (NASDAQ), AVROBIO INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), SYNTHORX INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), MORPHIC HOLDING INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), MERUS B V (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), AGENUS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), XBIOTECH INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), PERSONALIS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), MEDICINOVA INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), DERMIRA INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), AVID BIOSERVICES INC (NASDAQ), ARDELYX INC (NASDAQ), GERON CORP (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), RESTORBIO INC (NASDAQ), COMPUGEN (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), RECRO PHARMA INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), ATHERSYS INC (NASDAQ), KAMADA (NASDAQ), CHIASMA INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), BICYCLE THERAPEUTICS LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), AFFIMED N V (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), XOMA CORP (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), IMV INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), NANTKWEST INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), SESEN BIO INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), NOVAVAX INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), CHIMERIX INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), TREVENA INC (NASDAQ), VACCINEX INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), VERASTEM INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), ARAVIVE INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), CURIS INC (NASDAQ), OTONOMY INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), SYNLOGIC INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), IMMUTEP LTD SPON ADR EACH REP 100 ORD SHS (NASDAQ), EQUILLIUM INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), INFLARX N V (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), ORGENESIS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 2 ORD SHS (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), INMUNE BIO INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), EVOGENE LTD (NASDAQ), IVERIC BIO INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), VERMILLION INC (NASDAQ), SAVARA INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), ZAFGEN INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), BIOCARDIA INC (NASDAQ), SENESTECH INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), CONTRAFECT CORP (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), BIOCEPT INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), SOLIGENIX INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), OCUGEN INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), PRECIPIO INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), TOCAGEN INC (NASDAQ), VAXART INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), ATYR PHARMA INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADR EA REPR 20 ORD (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), ADVAXIS INC (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), TROVAGENE INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), OPGEN INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SPHERIX INC (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), NEURALSTEM INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ)
Global Peer AMGEN-T HKEx 599,701.000 9.116 9.612 7.1115 4.345
Global Peer CSL ASX 110,623.593 41.232 41.233 14.7831 1.089
Global Peer AGILENT TECHNOLOGIES INC NYSE 23,265.804 73.626 21.703 4.9012 0.815
Global Peer SINO BIOPHARM HKEx 141,842.566 13.238 13.662 4.1671 0.649
Global Peer WUXI BIO HKEx 100,215.905 134.175 104.894 10.3160 -
Global Peer BEIGENE HKEx 57,936.211 - - 4.7725 -
Global Peer 3SBIO HKEx 35,236.917 23.293 28.352 3.4730 -
Global Peer Lonza SGX 5,937.453 7.663 9.330 0.6935 4.766
Global Peer GENSCRIPT BIO HKEx 28,243.535 169.860 - 7.9647 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 2,707.452 43.181 - 2.7378 -
Other Global Peers FRONTAGE (HKEx), POLYNOVO LIMITED (ASX), VIVA BIOTECH (HKEx), HAOHAI BIOTEC (HKEx), AVITA MEDICAL LTD (ASX), MESOBLAST LTD (ASX), MYOVANT SCIENCES LTD (NYSE), ASCLETIS-B (HKEx), CKLIFE SCIENCES (HKEx), ESSEX BIO-TECH (HKEx), ARCUS BIOSCIENCES INC (NYSE), LEE'S PHARM (HKEx), KADMON HLDGS INC (NYSE), NEXT SCIENCE LTD (ASX), STARPHARMA HOLDINGS LIMITED (ASX), TELIX PHARMACEUTIC (ASX), DPHARMA (Bursa), 22ND CENTURY GROUP INC (NYSE American), PFENEX INC (NYSE American), BBI LIFE SCI (HKEx), ENZO BIOCHEM INC (NYSE), NEUREN PHARMACEUTICALS LTD (ASX), UNI-BIO GROUP (HKEx), RESAPP HEALTH LIMITED (ASX), LINEAGE CELL THERAPEUTICS INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), NANOVIRICIDES INC (NYSE American), CYNATA THERAPEUTICS LTD (ASX), PHYLOGICA LIMITED (ASX), CEL-SCI CORP (NYSE American), IMMUTEP LTD (ASX), PORT (SET), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), SYNTHETIC BIOLOGICS INC (NYSE American), CT ENTERPRISE (HKEx), IMUGENE LIMITED (ASX), ORTHOCELL LIMITED (ASX), BIONOMICS LTD (ASX), IBIO INC (NYSE American), MEMPHASYS LTD (ASX), ARMATA PHARMACEUTICALS INC (NYSE American), ONCOSIL MEDICAL LIMITED (ASX), RHINOMED LIMITED (ASX), REGENT PACIFIC (HKEx), ACTINOGEN MEDICAL LTD (ASX), BIOTRON (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), BIOSINO BIO-TEC (HKEx), EXTRAWELL PHAR (HKEx), INVEX THERAPEUTICS LTD NPV (ASX), ORAGENICS INC (NYSE American), KAZIA THERAPEUTICS LIMITED (ASX), PROTEOMICS INTL LABORATORIES LTD (ASX), ISORAY INC (NYSE American), ALTERITY THERAPEUTICS LIMITED (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), ADALTA LTD (ASX), PATRYS LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), IMMURON LIMITED (ASX), ANTEO DIAGNOSTICS LIMITED (ASX), Suntar Eco-City^ (SGX), REGENEUS LTD (ASX), GENETIC TECHNOLOGIES (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), CELLMID LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), BENITEC BIOPHARMA LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), MEDIBIO LIMITED (ASX), BIOXYNE LIMITED (ASX), MGRC (Bursa), LIVING CELL TECHNOLOGIES (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), AIM IMMUNOTECH INC (NYSE American), ANATARA LIFESCIENCES LTD (ASX), QT Vascular (SGX), AVECHO BIOTECHNOLOGY LTD (ASX), HAO WEN HLDGS (HKEx), MEGASUN (Bursa), TBG DIAGNOSTICS LTD (ASX), NOVITA HEALTHCARE LTD (ASX), CCP TECHNOLOGIES LTD (ASX), BPH ENERGY LIMITED (ASX), NANOLLOSE LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), ALCHEMIA LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.710
+1.43 %
10 Days -+3.230
+6.87 %
20 Days --6.520
-11.48 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 45.110 - 63.375 Change From 1 Year Low +5.150 % Change From 1 Year Low (%) +11.42
Change From 1 Year High -13.115 % Change From 1 Year High (%) -20.69
2 Years Range 45.110 - 63.375 Change From 2 Years Low +5.150 % Change From 2 Years Low (%) +11.42
Change From 2 Years High -13.115 % Change From 2 Years High (%) -20.69
5 Years Range 45.110 - 63.375 Change From 5 Years Low +5.150 % Change From 5 Years Low (%) +11.42
Change From 5 Years High -13.115 % Change From 5 Years High (%) -20.69
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company's products include Single Cell Gene Expression, Immune Profiling, CNV, ATAC, and Genome and Exome. 10X Genomics was founded by Serge Saxonov, Ben Hindson, Kevin D. Ness and Eduard Diviu Terradas on July 2, 2012 and is headquartered in Pleasanton, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
14 Oct 2019 49.310 51.220 49.000 50.260 83,555 -
11 Oct 2019 48.410 50.220 48.120 49.300 135,709 -
10 Oct 2019 50.550 50.550 48.100 48.440 222,083 -
09 Oct 2019 49.630 51.525 49.575 50.010 201,132 -
08 Oct 2019 50.000 51.270 49.000 49.550 285,066 -
07 Oct 2019 52.100 53.220 49.030 50.360 476,614 -
04 Oct 2019 48.000 53.340 47.820 51.450 322,434 -
03 Oct 2019 46.770 48.240 45.750 48.120 703,884 -
02 Oct 2019 46.780 47.230 45.110 46.070 519,610 -
01 Oct 2019 50.510 51.920 46.000 47.030 536,293 -
30 Sep 2019 51.050 52.000 49.250 50.400 168,913 -
27 Sep 2019 51.130 55.000 50.700 51.030 621,292 -
26 Sep 2019 52.780 53.690 46.620 49.990 596,339 -
25 Sep 2019 54.460 55.880 52.563 52.760 261,231 -
24 Sep 2019 61.000 61.000 54.000 54.300 713,776 -
23 Sep 2019 60.220 61.485 59.940 60.330 137,223 -
20 Sep 2019 61.710 62.420 59.820 60.500 392,008 -
19 Sep 2019 62.810 63.375 61.030 61.120 425,182 -
18 Sep 2019 56.850 62.270 55.650 62.000 1,589,799 -
17 Sep 2019 56.210 60.900 55.423 56.780 602,319 -
16 Sep 2019 52.450 56.000 52.010 55.200 269,767 -
13 Sep 2019 52.750 54.355 49.150 52.270 1,024,978 -
Summary
Current 2 Weeks
(01 Oct 2019 to 14 Oct 2019)		 50.510 53.340 45.110 50.260 3,486,380 -
Previous 2 Weeks
(17 Sep 2019 to 30 Sep 2019)		 56.210 60.900 45.110 50.400 5,508,082 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.